What research dose range is reported for Triple Threat Blend?

Published research literature reports Triple Threat Blend amounts of 10 mg/1mg/1mg, 3-4 days per week (8 weeks on/off cycle). PepCalcs reports these figures for reference only and does not recommend an amount.

What are the benefits of Triple Threat Blend?

Cellular energy. Fat loss. Mitochondrial support. Metabolic enhancement.

How is Triple Threat Blend administered?

Triple Threat Blend is typically administered via SQ.

Back to Library

Triple Threat Blend

Research Use OnlyEach component is in preclinical or early clinical research individually; the blend itself is investigational and not FDA approved.

NAD+, MOTS-c, and 5-Amino-1MQ Blend

Description

A synergistic combination targeting mitochondrial function, cellular energy, and fat metabolism. Combines NAD+ precursor with mitochondrial peptide and NNMT inhibitor for comprehensive metabolic support.

Dose:10 mg/1mg/1mg

Frequency:3-4 days per week (8 weeks on/off cycle)

Administration Method: SQ

CategoryWeight Loss

Half-LifeVaries by component: NAD+ minutes-hours; MOTS-c hours; 5-Amino-1MQ several hours.

Overview

The Triple Threat (NAD+ / MOTS-c / 5-Amino-1MQ) blend is marketed by research suppliers as a synergistic stack for mitochondrial energy, metabolic health, and longevity research. NAD+ replenishes a key redox cofactor, MOTS-c activates AMPK to enhance mitochondrial efficiency and insulin sensitivity, and 5-Amino-1MQ inhibits NNMT to preserve cellular NAD+ and methyl donors.

Mechanism of Action

Combination blend of NAD+ (sirtuin/PARP cofactor supporting cellular energy), MOTS-c (mitochondrial-derived peptide activating AMPK and improving glucose homeostasis), and 5-Amino-1MQ (NNMT inhibitor preserving NAD+ and methyl donors). The three converge on mitochondrial function, cellular energy, and metabolic regulation.

Benefits

•Cellular energy
•Fat loss
•Mitochondrial support
•Metabolic enhancement

Reported Side Effects

•Flushing (NAD+)
•Nausea
•Injection site reactions
•Limited long-term human data

Safety Notes

No clinical trials on the combined blend. Component-level safety data is limited. Research use only.

Scientific References

PubChem (NIH)Wikipedia

Related Weight Loss Peptides

Tesofensine

A serotonin-norepinephrine-dopamine reuptake inhibitor originally studied as an anti-obesity agent. Promotes weight loss through appetite suppression.

0.25-1 mg

Fragment 176-191

Somatotropin (176-191)

Fragment 176-191 is a synthetic C-terminal fragment of human growth hormone that promotes fat metabolism. It has shown promise in research for reducing blood sugar and aiding cartilage regeneration.

200-500 mcg

Tesamorelin/Ipamorelin Blend

Tesamorelin and Ipamorelin Blend

A potent growth hormone secretagogue combination. Tesamorelin provides sustained GHRH stimulation while Ipamorelin adds selective GH pulsatility for optimal fat loss and muscle building.

300 mcg/100mcg

AOD-9604

Anti-Obesity Drug 9604

A synthetic peptide analog of natural AOD-9604 fragment that stimulates lipolysis and inhibits lipogenesis without affecting IGF-1 or insulin.

300 mcg